You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海王生物(000078.SZ):2021年度預盈6000萬元-8500萬元 同比扭虧
格隆匯 01-27 20:16

格隆匯1月27日丨海王生物(000078.SZ)公佈2021年年度業績預吿,公司預計實現2021年度歸屬於上市公司股東的淨利潤為6000萬元-8500萬元,同比扭虧為盈;預計實現2021年度扣除非經常性損益後的淨利潤為4700萬元-7200萬元,同比扭虧為盈。

報吿期內,歸屬於上市公司股東的淨利潤實現扭虧為盈,主要系以下原因:

1、報吿期內,國內新冠肺炎疫情得到控制,公立醫療機構基本恢復接診,公司下屬經營單位對公立醫療機構的配送業務恢復正常,公司營業收入較上年同期有所增長。

2、計提商譽減值準備。報吿期內,國內新冠肺炎疫情得到控制,公立醫療機構恢復接診,公司下屬經營單位對公立醫療機構的配送業務恢復正常,公司下屬子公司營業收入較上年同期實現增長。公司根據《會計監管風險提示第8號—商譽減值》及《企業會計準則第8號—資產減值》的相關要求,對前期收購子公司形成的商譽進行了初步減值測試,預計本期計提的商譽減值額為17000萬元-21000萬元(實際計提金額需依據評估機構出具的商譽減值測試評估報吿確定),本報吿期計提商譽減值準備較上年同期有所減少,導致公司本報吿期業績扭虧為盈。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account